SCM
ROIV icon

Superstring Capital Management’s Roivant Sciences ROIV Stock Holding History

Superstring Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$907K Buy
+25,623
New +$757K 0.57% 26
2024
Q2 		– Sell
-531,019
Closed -$5.6M – 54
2024
Q1 		$5.6M Buy
531,019
+204,858
+63% +$2.21M 3.7% 9
2023
Q4 		$3.66M Buy
+326,161
New +$3.18M 2.61% 14

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Superstring Capital Management's ROIV Position: Q2 2026 in Review

Superstring Capital Management opened a new position in Roivant Sciences (ROIV) in Q2 2026: 25,623 shares worth $907K. The stake represents 0.57% of the portfolio and ranks #26 among its holdings. This is a return to the name: Superstring Capital Management previously reported a position in ROIV as recently as Q1 2024.

Superstring Capital Management first reported a position in ROIV in Q4 2023 and has held it in 3 quarters since. The position peaked at $5.6M in Q1 2024. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Superstring Capital Management held 25,623 shares of Roivant Sciences worth $907K as of Q2 2026.
  • Roivant Sciences was a new Superstring Capital Management position in Q2 2026.
  • Roivant Sciences made up 0.57% of Superstring Capital Management's portfolio in Q2 2026, its #26 holding.
  • Superstring Capital Management first reported a position in Roivant Sciences in Q4 2023 and has held it in 3 quarters since.
  • Superstring Capital Management's Roivant Sciences position peaked at $5.6M in Q1 2024.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Superstring Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.